Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms

NCT00666926 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasm
Prostatic Neoplasm
Pancreatic Neoplasm

Interventions

DRUG: PF00562271
DRUG: PF00562271
DRUG: PF00562271
DRUG: PF00562271

Sponsor

Verastem, Inc.